# A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

> **NCT02459457** · PHASE3 · COMPLETED · sponsor: **Fudan University** · enrollment: 321 (actual)

## Conditions studied

- Stage III Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Paclitaxel and Cisplatin
- **DRUG:** Paclitaxel and Fluorouracil
- **DRUG:** Paclitaxel and Carboplatin
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT02459457
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2022-02
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2022-02-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02459457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02459457, "A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02459457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*